Catalyst Wire Dossier Catalyst Wire Dossier

QLS31905

· Qilu Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for QLS31905, covering 2023-09-18 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer [Phase 3]

See pricing